CD20 peptides elicit a protective anti -tumor immune response in vivo

被引:0
|
作者
Teillaud, Jean-Luc [1 ,2 ,3 ,4 ]
Riller, Quentin [1 ,2 ,4 ]
Siberil, Sophie [1 ,2 ,4 ]
机构
[1] INSERM, UMRS 1138, Paris, France
[2] Cordeliers Res Ctr, Paris, France
[3] Univ Paris 05, Paris, France
[4] Univ Paris 06, Paris, France
来源
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
VAC5P.1126
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Vaccination with CD20 peptides induces a biologically active, specific immune response in mice
    Roberts, WK
    Livingston, PO
    Agus, DB
    Pinilla-Ibarz, J
    Zelenetz, A
    Scheinberg, DA
    BLOOD, 2002, 99 (10) : 3748 - 3755
  • [2] Deciphering CD20 immunogenicity to generate protective anti-tumor CD4+and CD8+T cells
    Siberil, Sophie
    Milcent, Benoit
    Riller, Quentin
    Deligne, Claire
    Hamieh, Mohamad
    Toutirais, Olivier
    Latouche, Jean-Baptiste
    Teillaud, Jean-Luc
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [3] Tumor-specific circRNAs elicit anti-tumor immune response via encoding cryptic antigenic peptides
    Huang, Di
    Chen, Jianing
    Su, Shicheng
    Song, Erwei
    CANCER RESEARCH, 2024, 84 (09)
  • [4] The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden
    Boross, Peter
    Jansen, J. H. Marco
    de Haij, Simone
    Beurskens, Frank J.
    van der Poel, Cees E.
    Bevaart, Lisette
    Nederend, Maaike
    Golay, Josee
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Leusen, Jeanette H. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (12): : 1822 - 1830
  • [5] Clinical indicators of response to CD20 upregulation on tumor cells by cytokines.
    Subramanian, A
    Venugopal, P
    Baseer, S
    Nirula, S
    Sivaraman, S
    O'Brien, TM
    O'Donnell, K
    Gregory, SA
    Jajeh, A
    Preisler, HD
    BLOOD, 2000, 96 (11) : 231B - 231B
  • [6] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04): : A59 - A59
  • [7] Response to: Monoclonal antibodies targeting CD20
    Klein, Christian
    Lammens, Alfred
    Schaefer, Wolfgang
    Georges, Guy
    Schwaiger, Manfred
    Moessner, Ekkehard
    Hopfner, Karl-Peter
    Umana, Pablo
    Niederfellner, Gerhard
    MABS, 2013, 5 (03) : 337 - 338
  • [8] Improved molecular design and immunization route of CD20 peptides induce antibody against human CD20 protein.
    Dao, T
    Antczak, C
    Boutsalis, G
    Kou, C
    Jaggi, J
    Kappel, B
    Pinilla-Ibarz, J
    Scheinberg, DA
    BLOOD, 2003, 102 (11) : 899A - 899A
  • [9] Molecular response to anti CD20 (Rituximab) therapy in relapsed follicular lymphoma.
    Giraldo, P
    Pelegrin, F
    Palomera, L
    Recasens, V
    Najera, MJ
    Perdiguer, L
    Puente, F
    Rubio-Felix, D
    BLOOD, 2001, 98 (11) : 135A - 135A
  • [10] MODULATION OF CD20 EXPRESSION ON B CELLS BY ANTI-CD20 ANTIBODIES
    Bellintani, Elaine C.
    de Marco, Renato
    Fantini, Renata
    Valim, Tiago
    Macedo, Denise
    Miyamoto, Yuriko
    Temin, Julia
    Gerbase-DeLima, Maria
    HUMAN IMMUNOLOGY, 2016, 77 : 138 - 138